Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRQIH.L Regulatory News (RQIH)

  • There is currently no data for RQIH

Program Management Update

29 Jul 2021 07:00

RNS Number : 8263G
Randall & Quilter Inv Hldgs Ltd
29 July 2021
 

 

Randall & Quilter Investment Holdings Ltd.

 

Program Management Update

 

Contracted Premium Reaches $1.8 billion with 67 Programs

 

29 July 2021

 

Randall & Quilter Investment Holdings Ltd, (AIM-RQIH) ("R&Q"), the leading non-life global specialty insurance company focusing on Program Management and Legacy Insurance businesses, announces a performance update for its Accredited Program Management business for the first six months of the year, ending 30 June 2021.

 

H1 2021 highlights

· Gross Written Premium of $445 million (H1 2020: $247 million), an 80% increase

· Fee Income of $25.2 million (H1 2020: $10.7 million), a 135% increase

· 60 programs (H1 2020: 36 programs), a 24 program increase

o 13 programs added in H1 2021

· Contracted Premium of $1.6 billion (H1 2020: $925 million), a 74% increase

 

Post period end developments

· In July 2021, Accredited added 7 new programs, bringing the total number of programs to 67, increasing the Contracted Premium to $1.8 billion.

 

William Spiegel, Executive Group Chairman, commented: "We are pleased to report continued strong momentum and growth in our Program Management business, having achieved profitability for the first time in 2020. We look forward to presenting a more detailed update at our interim results in September."

 

Notes:

1. Fee Income represents Program Fee Revenue and our share of earnings from minority stakes in MGAs.

2. Contracted Premium for Program Management is the Gross Written Premium that our distribution partners believe their programs will generate over a period of time. We expect a significant portion of Contracted Premium to become Gross Written Premium.

 

Ends

 

Enquiries to:

 

Randall & Quilter Investment Holdings Ltd

William Spiegel

Tel: +1 917-826-5877

 

Numis Securities Limited (Nominated Advisor and Joint Broker)

Stuart Skinner

Tel: 020 7260 1000

Charles Farquhar

 

Barclays Bank PLC (Joint Broker)

Mark Astaire

Milan Solanki

Tel: 020 7260 1000

 

 

Tel: 020 7632 2322

Tel: 020 7632 2322

FTI Consulting

Tom Blackwell

 

Tel: 020 3727 1051

 

 

Notes to Editors:

 

About R&Q 

 

R&Q is a non-life global speciality insurance company operating two core, highly complementary, businesses: Program Management and Legacy Insurance. Both these businesses are leaders in markets with high barriers to entry and significant growth opportunities. Legacy Insurance generates profits and capital extractions from expert management of legacy no-life insurance portfolios. Program Management generates commission income from its licensed (and rated) carriers in the US, EU and the UK, writing niches and profitable program business, largely on behalf of highly rated reinsurers.

 

Legal Entity Identifier (LEI): 2138006K1U38QCGLFC94

 

Website: www.rqih.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDVVLFLFDLBBBK
Date   Source Headline
29th Jul 20247:00 amRNSCancellation - R&Q INSURANCE HOLDINGS LTD
28th Jun 20246:07 pmRNSSale of Accredited to Onex Partners
27th Jun 20247:00 amRNSAppointment of Joint Provisional Liquidators
24th Jun 20247:00 amRNSUpdate
24th Jun 20247:00 amRNSR&Q agrees sale of Inceptum
20th Jun 20244:59 pmRNSTR-1: Notification of major holdings
20th Jun 20241:12 pmRNSTR-1: Notification of major holdings
19th Jun 20242:46 pmRNSTR-1: Notification of major holdings
19th Jun 20242:26 pmRNSTR-1: Notification of major holdings
19th Jun 20247:30 amRNSSuspension - R&Q Insurance Holdings Ltd
19th Jun 20247:00 amRNSUpdate
18th Jun 20242:19 pmRNSNotification of major holdings
17th Jun 20241:29 pmRNSTR-1: Notification of major holdings
14th Jun 20243:16 pmRNSTR-1: Notification of major holdings
13th Jun 20247:35 amRNSUpdate on proposed sale of Accredited
24th Apr 20245:40 pmRNSUpdate on proposed sale of Accredited
19th Apr 20247:00 amRNSAppointment of Non-Executive Directors
12th Apr 20247:00 amRNSUpdate on Trading and Sale of Accredited
12th Mar 20242:33 pmRNSTR-1: Notification of major holdings
1st Mar 20247:00 amRNSComment on recent press speculation
11th Jan 20244:01 pmRNSShareholders approve sale of Accredited
4th Jan 20244:27 pmRNSIncrease in the number of Treasury Shares
2nd Jan 20247:00 amRNSRetirement of Alan Quilter
22nd Dec 20237:00 amRNSUpdate on discussions with the BMA
21st Dec 202311:12 amRNSTR-1: Notification of major holdings
14th Dec 20237:00 amRNSPosting of Circular
16th Nov 20239:58 amRNSTR-1: Notification of major holdings
14th Nov 20237:00 amRNSUpdate on Proposed Sale of Accredited
27th Oct 20234:52 pmRNSPDMR/Director Shareholding and Total Voting Rights
26th Oct 20237:00 amRNSLoss Portfolio Transfer
26th Oct 20237:00 amRNSChange of External Auditor
20th Oct 20235:23 pmRNSProposed Sale of R&Q’s Program Management business
16th Oct 202310:59 amRNSTR-1: Notification of major holdings
29th Sep 20237:00 amRNSResults for the half year ended 30 June 2023
22nd Sep 20237:00 amRNSStatement re Press Comment
20th Sep 202311:55 amRNSTR-1: Notification of major holdings
20th Sep 202311:54 amRNSTR-1: Notification of major holdings
16th Aug 20233:36 pmRNSPDMR/Director Shareholding and Total Voting Rights
28th Jul 20233:18 pmRNSResult of Annual General Meeting
18th Jul 20233:22 pmRNSTR-1: Notification of major holdings
17th Jul 20237:00 amRNSAppointment of Non-Executive Director
30th Jun 202310:08 amRNSAppointment of Non-Executive Director
30th Jun 20237:00 amRNSPosting of Annual Report and Notice of AGM
29th Jun 20237:00 amRNSResults for the year ended 31 December 2022
26th Jun 20237:00 amRNSAccredited receives independent AM Best Rating
12th Jun 20237:00 amRNSR&Q raises up to $60 million of new equity
6th Jun 20235:31 pmRNSTR-1: Notification of major holdings
5th Jun 202311:23 amRNSTR-1: Notification of major holdings
2nd Jun 20233:50 pmRNSTR-1: Notification of major holdings
16th May 20239:27 amRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.